Circular 13 of 2022 Pharmacovigilance system requirements for Pharmaceutical Industry

Medicines Control Authority of Zimbabwe Follow

Medicines Control Authority of Zimbabwe @mcazofficial ·

19 Apr

Visit the Medicines Control Authority of Zimbabwe (MCAZ) at ZITF 2024! Visit stand 2A015 in Hall Two. Our team of experts will be there to respond to all your inquiries, and licensing issues. Learn more about this critical org and how it best serves you!

#ZITF2024 @MoHCCZim

Reply on Twitter 1781334704865587581 Retweet on Twitter 1781334704865587581 3 Like on Twitter 1781334704865587581 3 Twitter 1781334704865587581

Medicines Control Authority of Zimbabwe @mcazofficial ·

18 Apr

#HappyIndependenceDay MCAZ joins the nation in celebrating 44 years of independence.

#Zim44 #ZimAt44

Reply on Twitter 1780822379502923996 Retweet on Twitter 1780822379502923996 3 Like on Twitter 1780822379502923996 18 Twitter 1780822379502923996

Medicines Control Authority of Zimbabwe @mcazofficial ·

15 Apr

1/🚨[READ] The MCAZ would like to inform all stakeholders of a critical communication from the National Agency for Food and Drug Administration (NAFDAC) of Nigeria regarding the recall of Benylin Paediatric 100ml Syrup.

For more information https://www.mcaz.co.zw/wp-content/uploads/2024/04/MEDIA-RELEASE-Benylin-Recall-Statement.pdf

Reply on Twitter 1779885113418842144 Retweet on Twitter 1779885113418842144 15 Like on Twitter 1779885113418842144 11 Twitter 1779885113418842144

Medicines Control Authority of Zimbabwe @mcazofficial ·

9 Apr

1/ The Authority invites Medicines and Medical products registration applicants and other relevant stakeholders to participate in a virtual meeting titled "MCAZ feedback on the new system of processing applications for registration. - Circular 26 of 2023."

Reply on Twitter 1777708978480329105 Retweet on Twitter 1777708978480329105 2 Like on Twitter 1777708978480329105 4 Twitter 1777708978480329105

Circular 13 of 2022 Pharmacovigilance system requirements for Pharmaceutical Industry

QUICK LINKS

FACEBOOK FEED

TWITTER FEED

CONTACT US